Quantcast

Latest Sanofi Stories

2014-06-04 08:33:25

MONTREAL, June 4, 2014 /CNW Telbec/ - A Canadian study has identified a new strategy for improving the care of patients living with Type 2 Diabetes (T2D) by empowering them to manage their own insulin therapy. The START study (Self-Titration with Apidra® to Reach Target)(1), the first research of its kind, found that T2D patients adjusting their own insulin doses can control the disease and achieve blood sugar targets just as safely and effectively as patients whose treatment is...

2014-06-04 08:32:55

Dr. Kongsamut specializes in age-related and neuroscience/CNS disorders PLANTATION, Fla., June 4, 2014 /PRNewswire/ -- Neurotrope, Inc. (OTCQB: NTRP) announced today the appointment of Sam Kongsamut, Ph.D., as Executive Director, Pharmacology, effective immediately. In this role, Dr. Kongsamut will be responsible for accelerating the Company's product development efforts. Dr. Kongsamut is a neuroscientist with a specialized background in preclinical models used in identifying early...

2014-05-28 08:30:29

Companies anticipate providing over-the-counter (OTC) product to treat erectile dysfunction after expiration of certain patents PARIS and INDIANAPOLIS, May 28, 2014 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and Eli Lilly and Company (NYSE: LLY) today announced an agreement to pursue regulatory approval of nonprescription Cialis (tadalafil). Cialis is currently available by prescription only worldwide for the treatment of men with erectile dysfunction (ED). Under the terms of the...

2014-05-22 08:28:45

Seven-fold lower incidence of VTEs in patients treated with ISIS-FXIRx compared to enoxaparin CARLSBAD, Calif., May 22, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today positive top-line data from a Phase 2 comparator-controlled study evaluating the incidence of venous thrombolic events (VTE) in patients treated with ISIS-FXI(Rx) undergoing total knee replacement surgery, or total knee arthroplasty (TKA). ISIS-FXI(Rx) inhibits the production of Factor...

2014-05-12 23:10:28

Companies receiving the prestigious honors for partnering and business collaboration include Cisco, Covance, DNDi, Eli Lilly and Company, KPMG, NetApp, and Sanofi. Canton, MA (PRWEB) May 12, 2014 The Association of Strategic Alliance Professionals (ASAP), the world’s leading professional association dedicated to the practice of alliance management, announced its five 2014 Alliance Excellence Award winners at its recent Global Alliance Summit held in Scottsdale, Arizona. Companies and...

2014-05-12 12:30:47

$100,000 prize and access to additional expertise awarded to support "big data" genetic analysis to provide new clues to the higher incidence of ALS in veterans BRIDGEWATER, N.J., May 12, 2014 /PRNewswire/ -- Sanofi US announced the winner of its second Innovation Challenge: Collaborate Innovate. The winner, Veterans Advancing ALS/MND, is a partnership that comprises Innovative Solutions Consortium and Johns Hopkins University. In the spirit of collaboration, Sanofi's Partners in Patient...

2014-05-06 23:09:51

Hear from Sanofi Aventis how intelligent Central Statistical Monitoring techniques have been harnessed to improve data quality and oversight. The broadcast takes place on Wednesday, May 28, 2014 at 11:00am EDT (16:00 UK BST/ GMT +1). Toronto, Canada (PRWEB) May 06, 2014 Sanofi started to investigate general issues around scientific misconduct back in 2008 with IDDI (CluePoints’ parent company) and then implemented CSM with CluePoints since 2012. This session will showcase the impact...

2014-05-06 16:32:03

OTTAWA, May 6, 2014 /CNW/ - Health Canada today released the April 2014 issue of the Canadian Adverse Reaction Newsletter (CARN). This issue features an article on the risk of a potentially life-threatening condition called drug reaction with eosinophilia and systemic symptoms suspected of being associated with azithromycin, an antibiotic used to treat a variety of infections. It also includes an article on quetiapine, a drug used to treat certain psychiatric disorders, and...

2014-04-29 20:23:44

LONDON, April 29, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:The World Market for Orphan Drugshttp://www.reportbuyer.com/pharma_healthcare/therapeutic/world_market_orphan_drugs_1.htmlIn recent years, there has been a substantial increase in the number of drugs available to treat rare ("orphan") diseases. This comprehensive report, The World Market for Orphan Drugs, looks at this trend and provides estimates for the market opportunity in the U.S.,...

2014-04-29 08:36:15

PARIS, April 29, 2014 /PRNewswire/ -- Sanofi (NYSE: SNY; EURONEXT: SAN) Q1 2014 Change (reported) Change (CER) Net sales EUR7,842m -2.7% +3.5% Business net income(2) EUR1,547m -3.2% +5.6% Business EPS(1) EUR1.17 -3.3% +5.8% -------------- ------- ---- ---- In order to facilitate an understanding of our operational...


Word of the Day
baudekin
  • A rich embroidered or brocaded silk fabric woven originally with a warp of gold thread.
'Baudekin' seems to be an alternative form of 'baldachin,' from the Italian 'Baldacco,' Baghdad, the city where the material was made.
Related